Oncogenic pathway combinations predict clinical prognosis in gastric cancer

Chia Huey Ooi ¹, Tatiana Ivanova , Jeanie Wu

⁰Duke-NUS Graduate Medical School, Singapore.

Plos Genetics +

|

October 3, 2009

View abstract on PubMed

Summary

This study identifies key oncogenic pathways in gastric cancer (GC) linked to patient survival. Gastric cancer can be classified into distinct subgroups based on pathway activity, aiding in understanding disease behavior.

Area Of Science

Oncology
Molecular Biology
Bioinformatics

Background

Solid cancers display significant heterogeneity in oncogenic pathway deregulation.
Gastric cancer (GC) is a leading cause of cancer mortality globally.
Understanding major oncogenic pathways in GC is crucial for improving patient outcomes.

Purpose Of The Study

To identify major oncogenic pathways in gastric cancer (GC) associated with patient survival.
To stratify GC patients based on oncogenic pathway activation patterns.
To explore the role of pathway interactions in GC disease behavior.

Main Methods

Utilized gene expression signatures for an in silico strategy.
Mapped oncogenic pathway activation patterns in 301 primary gastric cancers.
Functionally validated pathway predictions in gastric cancer cell lines.

Main Results

Identified three key deregulated oncogenic pathways in over 70% of GCs: proliferation/stem cell, NF-kappaB, and Wnt/beta-catenin.
Demonstrated reproducible and significant survival differences across patient cohorts stratified by pathway combinations.
Showcased the ability to taxonomize individual GCs into biologically and clinically relevant subgroups based on pathway activity.

Conclusions

Gastric cancer heterogeneity can be characterized by specific oncogenic pathway deregulation.
Pathway interactions significantly influence GC disease behavior and patient survival.
In silico prediction of pathway activity enables large-scale study of interacting pathways in primary cancers.

Related Concept Videos